Irinotecan liposome

Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC

Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Exploratory Study of Irinotecan Liposomes in Maintenance Therapy of Metastatic Colorectal Cancer

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

A Study of Simmitinib Plus Irinotecan in Advanced Esophageal Squamous Cell Carcinoma

A Study to Investigate the Efficacy and Safety of Ivonescimab Combined With Irinotecan Liposome as Second-line Regimen for ES-SCLC

Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

A Study of Irinotecan Hydrochloride Liposome in Advanced Solid Tumors

Radiotherapy Combined With Irinotecan and Apatinib Followed by PD-1 Antibody and Apatinib for Advanced Solid Tumors

SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer